Indivumed will exhibit at the SITC Annual Meeting in National Harbor, USA, November 8–12

The 32nd Annual Meeting of the Society for Immunotherapy of Cancer (SITC) is one of the premier destinations for scientific exchange, education, and networking in the cancer immunotherapy field. Indivumed will be present at booth 507 and will attend the poster session on Saturday, November 11, from 12:30 to 2 p.m. and from 6:30 to 8 p.m. in the category Tumor Microenvironment (Mechanisms and Therapies). It will present a poster on the utilization of dual IHC and quantitative image analysis techniques to evaluate LAG-3-positive T cells in the tumor microenvironment of NSCLC tissue. For more information, please visit oraclebio.com/lag-3-positive-t-cells-clinical-tumor-blog.

http://www.sitcancer.org/2017/home

Please visit us at booth 507